{"id":6021,"date":"2022-04-14T09:48:11","date_gmt":"2022-04-14T07:48:11","guid":{"rendered":"https:\/\/www.rapharm.eu\/en\/?p=6021"},"modified":"2022-04-19T14:37:13","modified_gmt":"2022-04-19T12:37:13","slug":"eu-joint-implementation-and-preparedness-plan-for-ivdr","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/en\/eu-joint-implementation-and-preparedness-plan-for-ivdr\/","title":{"rendered":"EU: Joint implementation and preparedness plan for IVDR"},"content":{"rendered":"<style type=\"text\/css\"><\/style>\n<p>The Medical Device Coordination Group\n(MDCG) has issued a Joint Implementation and Preparedness Plan for Regulation\n(EU) 2017\/746 on <em>in vitro<\/em> diagnostic medical devices (IVDR). This is a\nliving document monitoring the implementation of IVDR. The updated version that\nhas been published following MDCG endorsement concerns the status and timelines\nof specific work items.<\/p>\n\n\n\n<p>Click <a href=\"https:\/\/ec.europa.eu\/health\/system\/files\/2022-04\/md_joint-impl-plan_en.pdf\">here <\/a>for more\ninformation.&nbsp;<\/p>\n\n\n\n<p><strong>Do you need additional knowledge or assistance in\nmeeting the requirements of MDR\/IVDR?<\/strong><\/p>\n\n\n\n<p>With the help of our <a href=\"https:\/\/www.rapharm.eu\/en\/actual-educations\/\">actual\neducations<\/a> and <a href=\"https:\/\/www.rapharm.eu\/en\/consulting-services\/\">consulting services<\/a>, we can help you meet the requirements of the MDR\/IVDR.<\/p>\n\n\n\n<p><strong>Resource:<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/ec.europa.eu\/health\/system\/files\/2022-04\/md_joint-impl-plan_en.pdf\">Joint implementation and preparedness plan for Regulation (EU) 2017\/746 on in vitro diagnostic medical devices (IVDR)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Medical Device Coordination Group (MDCG) has issued a Joint Implementation and Preparedness Plan for Regulation (EU) 2017\/746 on in vitro diagnostic medical devices (IVDR). This is a living document monitoring the implementation of IVDR. The updated version that has been published following MDCG endorsement concerns the status and timelines of specific work items. Click&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45,30],"tags":[],"class_list":["post-6021","post","type-post","status-publish","format-standard","hentry","category-novice-en","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU: Joint implementation and preparedness plan for IVDR - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU: Joint implementation and preparedness plan for IVDR - raPHARM\" \/>\n<meta property=\"og:description\" content=\"The Medical Device Coordination Group (MDCG) has issued a Joint Implementation and Preparedness Plan for Regulation (EU) 2017\/746 on in vitro diagnostic medical devices (IVDR). This is a living document monitoring the implementation of IVDR. The updated version that has been published following MDCG endorsement concerns the status and timelines of specific work items. Click...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-14T07:48:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-19T12:37:13+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/\",\"url\":\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/\",\"name\":\"EU: Joint implementation and preparedness plan for IVDR - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-04-14T07:48:11+00:00\",\"dateModified\":\"2022-04-19T12:37:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU: Joint implementation and preparedness plan for IVDR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU: Joint implementation and preparedness plan for IVDR - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/","og_locale":"en_US","og_type":"article","og_title":"EU: Joint implementation and preparedness plan for IVDR - raPHARM","og_description":"The Medical Device Coordination Group (MDCG) has issued a Joint Implementation and Preparedness Plan for Regulation (EU) 2017\/746 on in vitro diagnostic medical devices (IVDR). This is a living document monitoring the implementation of IVDR. The updated version that has been published following MDCG endorsement concerns the status and timelines of specific work items. Click...","og_url":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/","og_site_name":"raPHARM","article_published_time":"2022-04-14T07:48:11+00:00","article_modified_time":"2022-04-19T12:37:13+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/","url":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/","name":"EU: Joint implementation and preparedness plan for IVDR - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-04-14T07:48:11+00:00","dateModified":"2022-04-19T12:37:13+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/eu-skupni-nacrt-za-izvajanje-in-pripravljenost-na-ivdr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/en\/"},{"@type":"ListItem","position":2,"name":"EU: Joint implementation and preparedness plan for IVDR"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/comments?post=6021"}],"version-history":[{"count":2,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6021\/revisions"}],"predecessor-version":[{"id":6023,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6021\/revisions\/6023"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/media?parent=6021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/categories?post=6021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/tags?post=6021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}